Smith & Nephew SNATS Stock Forecast
NYSE: SNNHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SNN analyst consensus
Consensus (6 analysts)
hold
Avg. price target
$32.32+19.88%
- Strong buy 1
- Buy 0
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Smith & Nephew SNATS (2026-10-09), 1 rate the stock a buy or strong buy, 5 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $32.32, with a high estimate of $38.00 and a low estimate of $29.00. The average target implies upside of 19.9% from the current price of $26.96.
The spread between the highest and lowest targets is 31.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SNN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 17% |
| Buy | 0 | 0% |
| Hold | 5 | 83% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $29.00 | +7.57% |
| Average target | $32.32 | +19.88% |
| High target | $38.00 | +40.95% |